|
1）Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995; 40: 1561-8
|
|
|
|
2）Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001; 344: 732-8
|
|
|
|
|
|
3）Hamano H, Kawa S, Ochi Y, et al. Hydro-nephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet. 2002; 359: 1403-4
|
|
|
|
|
|
4）Kamisawa T, Funata N Hayashi Y, et al. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut. 2003; 52: 683-7
|
|
|
|
|
|
5）Kawaguchi K, Koike M, Tsuruta K, et al. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol. 1991; 22: 387-95
|
|
|
|
|
|
6）Notohara K, Burgart LJ, Yadav D, et al. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration. Clinicopathologic features of 35 cases. Am J Surg Pathol. 2003; 27: 1119-27
|
|
|
|
|
|
7）Zamboni G, Luttges J, Capelli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch. 2004; 445: 552-63
|
|
|
|
|
|
8）Chari ST, Kloeppel G, Zhang L, et al. Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreas. 2010; 39: 549-54
|
|
|
|
|
|
9）Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011; 40: 352-8
|
|
|
|
|
|
10）下瀬川徹，岡崎和一，神澤輝実，他．自己免疫性膵炎の国際コンセンサス診断基準．膵臓．2011; 26: 684-98
|
|
|
|
|
11）日本膵臓学会・厚生労働省難治性膵疾患に関する調査研究班: 自己免疫性膵炎臨床診断基準2011．膵臓．2012; 27: 17-25
|
|
|
|
|
12）Okazaki K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol. 2006; 41: 626-31
|
|
|
|
|
|
13）Masaki Y, Dong L, Kurose N, et al. Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis. 2009; 68: 1310-5
|
|
|
|
|
|
14）Kawano M, Saeki T, Nakashima H, et al. Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol. 2011; 15: 615-26
|
|
|
|
|
|
15）厚生労働省IgG4関連全身硬化性疾患の診断法の確立と治療方法の開発に関する研究班，厚生労働省難治性の肝胆道疾患に関する調査研究班，日本胆道学会．IgG4関連硬化性胆管炎臨床診断基準2012．胆道．2012; 26: 59-63
|
|
|
|
|
|
16）Ohara H, Okazaki K, Tsubouchi H, et al. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. J Hepatobiliary Pancreat Sci. 2012; 19: 536-42
|
|
|
|
|
|
17）Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease （IgG4-RD）, 2011. Mod Rheu-matol. 2012; 22: 21-30
|
|
|
|
|
|
18）IgG4関連全身硬化性疾患の診断法の確立と治療方法の開発に関する研究班・新規疾患，IgG4関連多臓器リンパ増殖性疾患（IgG4+MOLPS）の確立のための研究班．IgG4関連疾患包括診断基準2011．日内会誌．2012; 101: 795-804
|
|
|
|
|
|
19）Stone JH, Khosroshahi A, Deshpande V, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012; 64: 3061-7
|
|
|
|
|
|
20）Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012; 25: 1181-92
|
|
|
|
|
|
21）Zhang L, Notohara K, Levy MJ, et al. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol. 2007; 20: 23-8
|
|
|
|
|
|
22）Sah RP, Chari ST, Pannala R, et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterol. 2010; 139: 140-8
|
|
|
|
|
|
23）Kamisawa T, Chari ST, Giday SA, et al. Clinical profile of autoimmune pancreatitis and its histological subtypes: an international multicenter survey. Pancreas. 2011; 40: 809-14
|
|
|
|
|
|
24）Song TJ, Kim JH, Kim MH, et al. Comparison of clinical findings between histologically confirmed type 1 and type 2 autoimmune pancreatitis. J Gastroenterol Hepatol. 2012; 27: 700-8
|
|
|
|
|
|
25）Detlefsen S, Zamboni G, Frulloni L, et al. Clinical features and relapse rates after surgery in type 1 autoimmune pancreatitis differ from type 2: a study of 114 surgically treated European patients. Pancreatology. 2012; 12: 276-83
|
|
|
|
|
|
26）Zhang L, Chari S, Smyrk TC, et al. Autoimmune pancreatitis （AIP） type 1 and type 2: an international consensus study on histopathologic diagnostic criteria. Pancreas. 2011; 40: 1172-9
|
|
|
|
|
|
27）Detlefsen S, Drewes AM, Vyberg M, et al. Diagnosis of autoimmune pancreatitis by core needle biopsy: application of six microscopic criteria. Virchows Arch. 2009; 454: 531-9
|
|
|
|
|
|
28）Chang SY, Keogh K, Lewis JE, et al. Increased IgG4-positive plasma cells in granulomatosis with polyangiitis: a diagnostic pitfall of IgG4-related disease. Int J Rheumatol. 2012; 2012: 121702
|
|
|
|
|
|
29）Sato Y, Kojima M, Takata K, et al. Multicentric Castleman's disease with abundant IgG4-positive cells: a clinical and pathological analysis of six cases. J Clin Pathol. 2010; 63: 1084-9
|
|
|
|
|
|
30）Nagai Y, Hayama N, Kishimoto T, et al. Predominance of IgG4+ plasma cells and CD68 positivity in sclerosing angiomatoid nodular transformation （SANT）. Histopathology. 2008; 53: 495-8
|
|
|
|
|
|
31）Kuo TT, Chen TC, Lee LY. Sclerosing angiomatoid nodular transformation of the spleen （SANT）: clinicopathological study of 10 cases with or without abdominal disseminated calcifying fibrous tumors, and the presence of a significant number of IgG4+ plasma cells. Pathol Int. 2009; 59: 844-50
|
|
|
|
|
|
32）Roberts SS, Attanoos RL. IgG4+ Rosai-Dorfman disease of the lung. Histopathology. 2010; 56: 662-4
|
|
|
|
|
|
33）Strehl JD, Hartmann A, Aqaimy A. Numerous IgG4-positive plasma cells are ubiquitous in diverse localized non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders. J Clin Pathol. 2011; 64: 237-43
|
|
|
|
|
|
34）Yamamoto H, Yamaguchi H, Aishima S, et al. Inflammatory myofibroblastic tumor versus IgG4-related sclerosing disease and inflammatory pseudotumor: a comparative clinicopathologic study. Am J Surg Pathol. 2009; 1330-40
|
|
|
|
|
|
35）Yamamoto M, Takahashi H, Suzuki C, et al. Analysis of serum IgG subclasses in Churg-Strauss syndrome-the meaning of elevated serum levels of IgG4. Intern Med. 2010; 49: 1365-70
|
|
|
|
|
|
36）Wakamatsu R, Watanabe H, Suzuki K, et al. Hypocomplementemic urticarial vasculitis syndrome is associated with high levels of serum IgG4: a clinical manifestation that mimics IgG4-related disease. Intern Med. 2011; 50: 1109-12
|
|
|
|
|
|
37）Yamashita K, Haga H, Mikami Y, et al. Degree of IgG4+ plasma cell infiltration in retroperitoneal fibrosis with or without multifocal fibrosclerosis. Histopathology. 2008; 52: 404-9
|
|
|
|
|
|
38）Zen Y, Onodera M, Inoue D, et al. Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4. Am J Surg Pathol. 2009; 33: 1833-9
|
|
|
|
|
|
39）Zen Y, Nakanuma Y. IgG4-related disease: a cross-sectional study of 114 cases. Am J Surg Pathol. 2010; 34: 1812-9
|
|
|
|
|
|
40）Go H, Kim JE, Kim YA, et al. Ocular adnexal IgG4-related disease: comparative analysis with mucosa-associated lymphoid tissue lymphoma and other chronic inflammatory conditions. Histopathology. 2012; 60: 296-312
|
|
|
|
|
|
41）Karamchandani JR, Younes SF, Warnke RA, et al. IgG4-related systemic sclerosing disease of the ocular adnexa. Am J Clin Pathol. 2012; 137: 699-711
|
|
|
|
|
|
42）Wallace ZS, Khosroshahi A, Jakobiec FA, et al. IgG4-related systemic disease as a cause of “idiopathic” orbital inflammation, including orbital myositis, and trigeminal nerve involvement. Surv Ophthalmol. 2012: 57: 26-33
|
|
|
|
|
|
43）高比良雅之，安積淳．眼領域．In: 梅原久範，岡崎和一，監修，川茂幸，川野充弘，編．IgG4関連疾患アトラス―IgG4研究会モノグラフ―．金沢市：前田書店；2012．p. 54-61
|
|
|
|
|